{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:31:38Z","timestamp":1749033098404},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.medcli.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T16:08:43Z","timestamp":1490112523000},"page":"46","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Meningitis por Moraxella catarrhalis durante tratamiento con certolizumab"],"prefix":"10.1016","volume":"149","author":[{"given":"Jonathan","family":"Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhon","family":"Ossenkopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Pe\u00f1arroja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.02.001_bib0030","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: A TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J."},{"key":"10.1016\/j.medcli.2017.02.001_bib0035","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA."},{"key":"10.1016\/j.medcli.2017.02.001_bib0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/annrheumdis-2013-203660","article-title":"Update on the safety profile of certolizumab pegol in rheumatoid arthritis: An integrated analysis from clinical trials","volume":"74","author":"Bykerk","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.02.001_bib0045","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.crohns.2012.06.012","article-title":"Meningococcal meningoencephalitis after certolizumab pegol treatment in a patient with Crohn's disease","volume":"7","author":"Majumder","year":"2013","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.medcli.2017.02.001_bib0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.annemergmed.2012.05.040","article-title":"Can broad-range 16S ribosomal ribonucleic acid gene polymerase chain reactions improve the diagnosis of bacterial meningitis? A systematic review and meta-analysis","volume":"60","author":"Srinivasan","year":"2012","journal-title":"Ann Emerg Med."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317301422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317301422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T09:53:10Z","timestamp":1535968390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317301422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0025775317301422"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.02.001","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningitis por Moraxella catarrhalis durante tratamiento con certolizumab","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}